Optimising Management of Angina

Optimising Management of Angina (OMA) is a cluster randomized controlled trial of a multi-faceted decision support and educational intervention within chest pain clinics across England. Chest pain is a worrying symptom and in some people it May Be caused by heart disease and is called angina. This is a pain or discomfort in the chest caused by narrowing of the coronary arteries of the heart. OMA looks at ways of improving the care of people suffering with such chest pain or discomfort.

Objectives

• To determine the cumulative impact on patient outcome of missed opportunities for improving patient outcome, from the beginning to the end of the patient journey, across five of the most common symptomatic coronary presentations, assessing inequalities in care and outcome.

• To determine at the level of the individual hospital the extent to which the organisation and processes of care have an impact on the patient journey. We will assess how variations measured at hospital level are impacted by the quality of primary care.

• To establish the effectiveness and cost-effectiveness of a multi-faceted intervention targeting initial specialist management at hospital chest pain clinics of patients early in the symptomatic phase of the patient journey.

• To determine whether novel biomarkers are a cost-effective addition to existing clinical information in predicting the progression of chronic stable angina to acute fatal and non-fatal events.

Collaborators

OMA is a collaboration between:

• University College London
• University of Bristol
• Queen Mary University of London

Funding

OMA is funded by the NHS National Institute of Health Research (NIHR)